Corporate ActionOct 5, 2026, 04:26 PM
SeaStar Medical Raises $3.3M via Warrant Exercise, Issues New Warrants
AI Summary
SeaStar Medical Holding Corporation announced the exercise of certain outstanding common stock purchase warrants, resulting in approximately $3.3 million in gross proceeds. The company entered into definitive agreements to allow holders to exercise warrants at a reduced price of $3.866 per share, purchasing an aggregate of 854,002 shares. In consideration, SeaStar Medical will issue new unregistered Series A and Series B warrants exercisable for up to an aggregate of 1,708,004 shares of common stock, with an exercise price of $3.616 per share and varying terms. The net proceeds are intended for general corporate purposes. H.C. Wainwright & Co. served as the exclusive placement agent for the offering.
Key Highlights
- SeaStar Medical announced the exercise of warrants for approximately $3.3 million in gross proceeds.
- Holders exercised Prior Warrants at a reduced price of $3.866 per share, purchasing 854,002 shares.
- The company issued new Series A and Series B warrants exercisable for up to 1,708,004 shares.
- New warrants have an exercise price of $3.616 per share, with terms of 5 years and 18 months.
- H.C. Wainwright & Co. acted as exclusive placement agent, receiving fees and warrants for 59,780 shares.
- Net proceeds will be used for general corporate purposes, including working capital and capital expenditures.
Price Impact
More from ICU